A detailed history of Msh Capital Advisors LLC transactions in Medtronic PLC stock. As of the latest transaction made, Msh Capital Advisors LLC holds 14,327 shares of MDT stock, worth $1.33 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
14,327
Previous 13,358 7.25%
Holding current value
$1.33 Million
Previous $1.2 Billion 4.54%
% of portfolio
0.36%
Previous 0.56%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$79.61 - $92.24 $77,142 - $89,380
969 Added 7.25%
14,327 $1.14 Billion
Q3 2024

Feb 13, 2025

BUY
$76.84 - $91.03 $18,057 - $21,392
235 Added 1.61%
14,799 $1.33 Billion
Q2 2024

Feb 13, 2025

BUY
$78.71 - $87.02 $92,799 - $102,596
1,179 Added 8.81%
14,564 $1.15 Billion
Q1 2024

Feb 13, 2025

BUY
$82.84 - $88.09 $35,207 - $37,438
425 Added 3.28%
13,385 $1.17 Billion
Q4 2023

Feb 13, 2025

SELL
$69.43 - $83.43 $45,337 - $54,479
-653 Reduced 4.8%
12,960 $1.07 Billion
Q3 2023

Feb 13, 2025

BUY
$78.22 - $90.4 $35,277 - $40,770
451 Added 3.43%
13,613 $1.07 Billion
Q2 2023

Feb 13, 2025

BUY
$79.47 - $91.38 $6,119 - $7,036
77 Added 0.59%
13,162 $1.16 Billion
Q1 2023

Feb 13, 2025

BUY
$76.72 - $87.58 $18,259 - $20,844
238 Added 1.85%
13,085 $1.05 Billion
Q4 2022

Feb 13, 2025

SELL
$76.18 - $87.74 $50,354 - $57,996
-661 Reduced 4.89%
12,847 $998 Million
Q3 2022

Feb 13, 2025

SELL
$80.75 - $95.31 $66,134 - $78,058
-819 Reduced 5.72%
13,508 $1.09 Billion
Q2 2022

Feb 13, 2025

BUY
$87.4 - $113.09 $286,759 - $371,048
3,281 Added 32.56%
13,358 $1.2 Billion
Q1 2022

Feb 13, 2025

BUY
$100.58 - $112.38 $126,730 - $141,598
1,260 Added 14.29%
10,077 $1.12 Billion
Q4 2021

Feb 13, 2025

BUY
$99.53 - $127.75 $877,556 - $1.13 Million
8,817 New
8,817 $912 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $123B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Msh Capital Advisors LLC Portfolio

Follow Msh Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msh Capital Advisors LLC with notifications on news.